Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Genotype 5 HCV”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Large-scale testing (Phase 3)Study completedNCT02032888
What this trial is testing

Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 238
Testing effectiveness (Phase 2)Study completedNCT02081079
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 4 or 5 HCV Infection

Who this might be right for
Chronic Genotype 4 HCVChronic Genotype 5 HCV
Gilead Sciences 85
Testing effectiveness (Phase 2)Study completedNCT02765490
What this trial is testing

Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Research & Development, LLC 365
Testing effectiveness (Phase 2)Study completedNCT00537407
What this trial is testing

Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment

Who this might be right for
Chronic Hepatitis C
Debiopharm International SA 50
Early research (Phase 1)Study completedNCT01181024
What this trial is testing

A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic, Healthy Volunteer
Hoffmann-La Roche 82
Testing effectiveness (Phase 2)Study completedNCT01121731
What this trial is testing

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus InfectionGenotype 1Treatment-Experienced Patients+1 more
Digna Biotech S.L. 70
Large-scale testing (Phase 3)Study completedNCT02966795
What this trial is testing

Of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 84
Testing effectiveness (Phase 2)Study completedNCT02254707
What this trial is testing

Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 96
Testing effectiveness (Phase 2)Ended earlyNCT02956629
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 282
Large-scale testing (Phase 3)Study completedNCT02651194
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
AbbVie 104
Testing effectiveness (Phase 2)Ended earlyNCT02759315
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)Study completedNCT01858766
What this trial is testing

Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 379
Large-scale testing (Phase 3)Study completedNCT02243293
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C Virus
AbbVie 694
Testing effectiveness (Phase 2)Study completedNCT03036839
What this trial is testing

Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 95
Large-scale testing (Phase 3)Study completedNCT02738138
What this trial is testing

Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 153
Early research (Phase 1)Study completedNCT01740791
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 103
Large-scale testing (Phase 3)Study completedNCT01641640
What this trial is testing

Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 328
Large-scale testing (Phase 3)Study completedNCT02939989
What this trial is testing

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Who this might be right for
Hepatitis C Virus Infection
AbbVie 33
Large-scale testing (Phase 3)Study completedNCT02707952
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C VirusHepatitis C Virus
AbbVie 295
Large-scale testing (Phase 3)Study completedNCT02642432
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis

Who this might be right for
Hepatitis C Virus InfectionChronic Hepatitis CCompensated Cirrhosis
AbbVie 146
Next Page